WINDTREE THERAPEUTICS INC /DE/ Convertible Notes Payable, Current
WINDTREE THERAPEUTICS INC /DE/ (WINT) had Convertible Notes Payable, Current of $2.59 million as of 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Notes and Loans Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2025-11-19
- 2025-09-30: Convertible Notes Payable, Current $2.59M.
- 2025-06-30: Convertible Notes Payable, Current $7.78M.
- 2024-12-31: Convertible Notes Payable, Current $0.00.
- 2018-09-30: Convertible Notes Payable, Current $969.00K.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2025-09-30 | $2.59M 10-Q · filed 2025-11-19 |
| 2025-06-30 | $7.78M 10-Q · filed 2025-08-19 |
| 2024-12-31 | $0.00 10-Q · filed 2025-11-19 |
| 2018-09-30 | $969.00K 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |